Replies to post #320189 on Innovation Pharmaceuticals Inc (IPIX)

[HolesInMyPockitz]

Farrell, if we have a high SI against COVID, is it safe to assume that our SI should also be fairly high on other respiratory illnesses?

Im hoping we get that extra grant money (on top of trial grant money) for our RBL’s to research Brilacidin against other respiratory conditions as mentioned in the 6/11 PR:


“The proposed research aims to evaluate Brilacidin as a potential pan-coronavirus therapeutic, for treating SARS-CoV-2, SARS-CoV-1 and MERS-CoV, including extending the current in vitro testing of Brilacidin to in vivo testing. Longer-term objectives include potentially performing additional research to develop Brilacidin as a broad-spectrum antiviral, with possible application beyond coronaviruses, e.g., treating other viruses, such as encephalitic alphaviruses and filoviruses.”